IrelandResearchers at Queen’s University Belfast have developed a dissolvable 3D-printed patch designed to treat localized skin cancer. The patch uses microneedles to deliver two anti-cancer drugs, curcumin and 5-fluorouracil, directly to the affected skin area. This method reduces the need for repeated topical treatments or invasive procedures like injections, potentially making skin cancer treatment less painful and more convenient for patients. The technology involves a one-step 3D-printing process that integrates the drugs into the microneedles during manufacturing, enhancing drug delivery efficiency and allowing for controlled release. The study, led by PhD student Rutuja N Meshram and Professor Dimitrios A Lamprou, highlights the potential of advanced manufacturing techniques in revolutionizing medicine delivery, with implications for personalized and patient-friendly healthcare solutions.
Bias read (Center): The article presents a scientific development without overt ideological framing. It focuses on the technical aspects of the 3D-printed patch, its benefits for patients, and its potential impact on healthcare delivery. There is no explicit political commentary or advocacy for specific policies, and a
